This application requests continuation of funds for years 06-10 for the Resource on Population Kinetics (RFPK-also referred to as the Resource). RFPK's major goal is the development, application and dissemination of modeling methodology and software tools for biomedical uses in defining, understanding and managing health and disease. This goal is achieved by promoting the application of integrated systems modeling in biomedical research. This is done by providing consultation in model development and experimental design, by offering educational programs, and by developing new methods for incorporation in state-of-the-art software tools. Modern methods of scientific computing, in conjunction with inexpensive and powerful hardware, are driving a dynamic paradigm shift in how state-of-the-art scientific, engineering and business research are performed. RFPK is at the forefront of this shift in the biomedical community in its ability to communicate and collaborate with diverse disciplines in order to conduct its research. This multidisciplinary group is comprised of faculty, staff, students and collaborators in various fields of medicine, mathematics, statistics, software engineering, and the pharmaceutical industry. This research model unifies concept development, experimentation, simulation and implementation. Examples of this new approach in action are the human genome project, the design of the Boeing 777, and the design of financial derivatives. Factors driving this approach are the need to understand and manage complex dynamical systems, the need for accurate descriptions of physical phenomena, and the need for efficiency in the use of funds for research and development. The full impact of this paradigm shift has not reached the biomedical research community. The problem is rooted in the absence of software tools and educational programs targeted at the development of modeling skills for this community. A program that integrates both software development and education must be designed to answer this need. RFPK addresses this need directly in its specific aims, which are to: (1) develop new modeling methodologies for biological systems; (2) specify, design, develop, test, validate and maintain new software tools incorporating cutting-edge mathematics, statistics and computer science; (3) provide service to the research community through collaboration and consultation; (4) provide educational programs for the research community in systems modeling applications; and (5) disseminate RFPK technology and expertise via diverse educational programs that integrate medicine, statistics, computer science and bioengineering in a comprehensive problem-solving approach. Making these new tools and methods available to a broad audience is a complex problem that is best accomplished on a university campus. RFPK has assembled a multidisciplinary team consisting of scientific experts in model development and testing who collaborate with mathematicians, statisticians, and software engineers. RFPK involves four major universities, all of which contribute unique expertise to the individual projects. Its Administrative Core is located at the University of Washington.

National Institute of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Biotechnology Resource Grants (P41)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-SSS-8 (30))
Program Officer
Peng, Grace
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Biomedical Engineering
Schools of Engineering
United States
Zip Code
Germovsek, Eva; Kent, Alison; Metsvaht, Tuuli et al. (2016) Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants. Antimicrob Agents Chemother 60:4869-77
McCune, Jeannine S; Mager, Donald E; Bemer, Meagan J et al. (2015) Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipients. Cancer Chemother Pharmacol 76:85-96
McCune, Jeannine S; Vicini, Paolo; Salinger, David H et al. (2015) Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration. Cancer Chemother Pharmacol 75:67-75
Ghosh, Subhojit (2014) A differential evolution based approach for estimating minimal model parameters from IVGTT data. Comput Biol Med 46:51-60
Goodpaster, Bret H; Bertoldo, Alessandra; Ng, Jason M et al. (2014) Interactions among glucose delivery, transport, and phosphorylation that underlie skeletal muscle insulin resistance in obesity and type 2 Diabetes: studies with dynamic PET imaging. Diabetes 63:1058-68
Dalla Man, Chiara; Piccinini, Francesca; Basu, Rita et al. (2013) Modeling hepatic insulin sensitivity during a meal: validation against the euglycemic hyperinsulinemic clamp. Am J Physiol Endocrinol Metab 304:E819-25
Hennig, Stefanie; Standing, Joseph F; Staatz, Christine E et al. (2013) Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis. Clin Pharmacokinet 52:289-301
Lewis, Lionel D; Miller, Antonius A; Owzar, Kouros et al. (2013) The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance). Pharmacogenet Genomics 23:29-33
Aregbe, Abdulateef O; Sherer, Eric A; Egorin, Merrill J et al. (2012) Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors. Cancer Chemother Pharmacol 70:201-5
Li, Hong; Mager, Donald E; Bemer, Meagan J et al. (2012) A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipients. J Clin Pharmacol 52:1654-64

Showing the most recent 10 out of 153 publications